AKTX
Akari Therapeutics (AKTX)
$14
About Akari Therapeutics (AKTX)
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in Tampa, FL.
Details
Daily high
$0.15
Daily low
$0.13
Price at open
--
52 Week High
$1.58
52 Week Low
$0.13
Market cap
4.5M
Dividend yield
0.00%
Volume
7
Avg. volume
450,453
P/E ratio
-.02
Akari Therapeutics News
Details
Daily high
$0.15
Daily low
$0.13
Price at open
--
52 Week High
$1.58
52 Week Low
$0.13
Market cap
4.5M
Dividend yield
0.00%
Volume
7
Avg. volume
450,453
P/E ratio
-.02